Quick10K

⚲

Differential Brands Group

Filings

10-Q	2019-09-30	Filed 2019-11-14
10-Q	2019-06-30	Filed 2019-08-14
10-Q	2019-03-31	Filed 2019-05-20
10-K	2018-12-31	Filed 2019-05-16
10-Q	2018-09-30	Filed 2018-11-14
10-Q	2018-06-30	Filed 2018-08-14
10-Q	2018-03-31	Filed 2018-05-15
10-K	2017-12-31	Filed 2018-04-02
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-14
10-Q	2017-03-31	Filed 2017-05-15
10-K	2016-12-31	Filed 2017-03-30
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-16
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-11-30	Filed 2016-02-29
10-Q	2015-08-31	Filed 2015-10-13
10-Q	2015-05-31	Filed 2015-07-10
10-Q	2015-02-28	Filed 2015-04-09
10-K	2014-11-30	Filed 2015-02-13
10-Q	2014-08-31	Filed 2014-10-09
10-Q	2014-05-31	Filed 2014-07-10
10-Q	2014-02-28	Filed 2014-04-09
10-K	2013-11-30	Filed 2014-02-13
10-Q	2013-08-31	Filed 2013-10-15
10-Q	2013-02-28	Filed 2013-04-15
10-K	2012-11-30	Filed 2013-02-21
10-Q	2012-08-31	Filed 2012-10-15
10-Q	2012-05-31	Filed 2012-07-16
10-Q	2012-02-29	Filed 2012-04-12
10-K	2011-11-30	Filed 2012-02-28
10-Q	2011-08-31	Filed 2011-10-11
10-Q	2011-05-31	Filed 2011-07-11
10-Q	2011-02-28	Filed 2011-04-11
10-K	2010-11-30	Filed 2011-02-10
10-Q	2010-08-31	Filed 2010-10-14
10-Q	2010-05-31	Filed 2010-07-15
10-Q	2010-02-28	Filed 2010-04-08
10-K	2009-11-30	Filed 2010-02-03

Reports

8-K	2020-10-09
8-K	2020-09-21
8-K	2020-06-30
8-K	2020-05-18
8-K	2020-05-11
8-K	2020-04-21
8-K	2020-04-11
8-K	2020-03-30
8-K	2020-03-29
8-K	2019-12-05
8-K	2019-11-14
8-K	2019-10-03
8-K	2019-09-10
8-K	2019-07-30
8-K	2019-06-24
8-K	2019-06-07
8-K	2019-04-25
8-K	2019-04-18
8-K	2019-04-17
8-K	2019-04-09
8-K	2018-12-31
8-K	2018-11-14
8-K	2018-11-06
8-K	2018-11-05
8-K	2018-10-30
8-K	2018-10-29
8-K	2018-10-29
8-K	2018-09-28
8-K	2018-08-14
8-K	2018-06-27
8-K	2018-06-27
8-K	2018-05-15
8-K	2018-04-02
8-K	2018-01-18

Differential Brands Group Financials

DFBG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	12	13	12	12	13	13	14	15	16	1	26	18	21	1	12	12	0	2	11	8	4	6	4	6	3	8	4	5	4	30	25	14	19
Accounts Receivable	2	2	2	2	1	1	2	3	2	5	4	5	11	3	2	1	0	1	2	2	3	3	23	17	24	5	25	18	21	28	26	25	18
Inventory	25	23	28	30	32	31	31	31	34	53	54	58	58	61	58	49	15	13	27	27	30	24	28	31	38	32	34	31	34	343	294	416	443
PP&E	6	5	5	6	9	11	7	7	7	15	7	6	6	13	5	5	2	2	14	13	13	21	10	10	9	22	8	8	7	102	93	94	91
Assets	81	80	85	87	89	86	88	89	92	223	221	222	227	204	185	173	172	76	168	156	175	166	169	169	178	174	177	168	169	1,859	2,002	2,165	2,155
Accounts Payable																						7				7				290
Long-Term Debt										93	59	59	59	92	93	93	93	34	82	79	94	93	97	97	101	101	88	86	89	1,360	1,404	1,492	1,416
Liabilities	17	15	19	19	20	14	22	22	25	157	158	154	159	163	165	157	149	65	115	107	125	122	126	129	138	129	120	117	128	1,776	1,997	2,238	2,234
Stockholders' Equity	65	65	66	68	69	72	66	67	67	66	63	68	69	41	20	17	23	11	53	49	50	45	43	39	40	45	57	51	41	83	5	-73	-79


Income Statement ($MM)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	24	25	26	29	30	34	29	31	29	50	47	48	53	41	43	47	19	19	35	32	41	42	40	36	42	45		36	40		529	423	712
Cost of Revenue	14	14	13	15	16	18	15	17	17	29	26	26	28	24	25	28	11	13	15	15	21	20	21	20	24	26		21	23		410	312	534
Gross Profit	10	12	13	14	14	16	14	14	13	22	21	23	24	16	18	19	8	6	20	17	20	22	19	16	18	19	16	14	17		119	112	178
R&D
SG&A	11	12	11	10	11	12	11	11	13	19	19	18	19	20	20	18	11	13	22	19	21	21	17	15	15	17	15	19	25		113	103	99
Tax	-1	0	1	3	1	1	-0	1	-0	1	-2	2	0	-5	14	0	-13	-4	1	-2	-2	-0	0	2	0	-6	1	0	0		2	-0	0
Net Income																			-6	-4	-3	-5	-2	-4	-0	4	-4	-6	-11		-82	-79	-9


Cash Flow ($MM)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		3	-1	-2	6	3	1	1	2	4	2	-6	-2	-4	8	3	-7	-3	-15	2	-6	4	-3	2	-6	5	-4	4	-4		-347	-99	-88
Cash Investing		-0	-0	-1	-1	-1	-0	-0	-1	-66	-0	-1	-0	-0	-0	-0	0	-0	-7	-0	-12	-1	-0		-0	-0	-0	-0	-0		303	9	176
Cash Financing		-1	1	2	-4	-1	0	0	-1	47	-3	7	3	4	-8	-3	6	5	31	-3	14	-1	1		3	0	0	-3	2		40	79	-84